Clover Health Investments Stock Forecast, Price & News

+0.17 (+2.09 %)
(As of 09/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume22.35 million shs
Average Volume35.76 million shs
Market Capitalization$3.41 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CLOV News and Ratings via Email

Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter.

Clover Health Investments logo

About Clover Health Investments

Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.01 out of 5 stars

Medical Sector

1207th out of 1,349 stocks

Hospital & Medical Service Plans Industry

13th out of 13 stocks

Analyst Opinion: 0.7Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Clover Health Investments (NASDAQ:CLOV) Frequently Asked Questions

Is Clover Health Investments a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. There are currently 3 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" Clover Health Investments stock.
View analyst ratings for Clover Health Investments
or view top-rated stocks.

What stocks does MarketBeat like better than Clover Health Investments?

Wall Street analysts have given Clover Health Investments a "Sell" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Clover Health Investments wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Clover Health Investments?

Clover Health Investments saw a increase in short interest during the month of August. As of August 13th, there was short interest totaling 30,270,000 shares, an increase of 19.8% from the July 29th total of 25,260,000 shares. Based on an average daily volume of 56,340,000 shares, the days-to-cover ratio is currently 0.5 days.
View Clover Health Investments' Short Interest

When is Clover Health Investments' next earnings date?

Clover Health Investments is scheduled to release its next quarterly earnings announcement on Wednesday, November 10th 2021.
View our earnings forecast for Clover Health Investments

What guidance has Clover Health Investments issued on next quarter's earnings?

Clover Health Investments updated its FY 2021 earnings guidance on Wednesday, September, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.40 billion-$1.50 billion, compared to the consensus revenue estimate of $811.48 million.

What price target have analysts set for CLOV?

5 Wall Street analysts have issued 1-year price objectives for Clover Health Investments' shares. Their forecasts range from $7.00 to $10.00. On average, they expect Clover Health Investments' share price to reach $9.00 in the next twelve months. This suggests a possible upside of 8.3% from the stock's current price.
View analysts' price targets for Clover Health Investments
or view top-rated stocks among Wall Street analysts.

Who are Clover Health Investments' key executives?

Clover Health Investments' management team includes the following people:
  • Mr. Vivek Garipalli, Co-Founder, CEO & Chairman of Directors (Age 42)
  • Mr. Andrew Toy, Co-Founder, Pres, CTO & Director (Age 42, Pay $427.19k)
  • Ms. Gia Lee Esq., Gen. Counsel & Sec. (Age 51, Pay $425.96k)
  • Mr. Joseph Wagner, Chief Financial Officer (Age 47)
  • Ms. Jamie L. Reynoso, Chief Operating Officer (Age 51)
  • Dr. Kumar Dharmarajan, Chief Scientific Officer (Age 41)
  • Mr. Derrick L. Nueman, Head of Investor Relations & Corp. strategy
  • Ms. Wendy Richey, Chief Compliance Officer
  • Ms. Rachel Fish, Chief People Officer
  • Dr. Sophia Chang M.D., M.P.H., Chief Clinical Informatics Officer (Age 60)

Who are some of Clover Health Investments' key competitors?

What is Clover Health Investments' stock symbol?

Clover Health Investments trades on the NASDAQ under the ticker symbol "CLOV."

Who are Clover Health Investments' major shareholders?

Clover Health Investments' stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (2.34%), Susquehanna International Group LLP (0.00%), BlackRock Inc. (0.54%), Citadel Advisors LLC (0.00%), IMC Chicago LLC (0.00%) and Geode Capital Management LLC (0.25%).

Which major investors are selling Clover Health Investments stock?

CLOV stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Lakewood Capital Management LP, Bank of Montreal Can, Goldman Sachs Group Inc., Bank of America Corp DE, Alberta Investment Management Corp, Warberg Asset Management LLC, and Squarepoint Ops LLC.

Which major investors are buying Clover Health Investments stock?

CLOV stock was acquired by a variety of institutional investors in the last quarter, including Susquehanna International Group LLP, Citadel Advisors LLC, Simplex Trading LLC, Bloom Tree Partners LLC, IMC Chicago LLC, State Street Corp, Morgan Stanley, and Morgan Stanley.

How do I buy shares of Clover Health Investments?

Shares of CLOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Clover Health Investments' stock price today?

One share of CLOV stock can currently be purchased for approximately $8.31.

How much money does Clover Health Investments make?

Clover Health Investments has a market capitalization of $3.41 billion.

How many employees does Clover Health Investments have?

Clover Health Investments employs 458 workers across the globe.

What is Clover Health Investments' official website?

The official website for Clover Health Investments is

Where are Clover Health Investments' headquarters?

Clover Health Investments is headquartered at 317 University Ave Suite 200, Palo Alto CA, 94301.

How can I contact Clover Health Investments?

Clover Health Investments' mailing address is 317 University Ave Suite 200, Palo Alto CA, 94301. The company can be reached via phone at 201-432-2133 or via email at [email protected].

This page was last updated on 9/20/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.